RT+/-chemotherapy group | non-RT + chemotherapy group | ||
---|---|---|---|
No.of patients (%) | No.of patients (%) | P value | |
Grade3-5 Anemia | 0.808 | ||
No | 33 (75.0 %) | 32 (72.7 %) | |
Yes | 11 (25.0 %) | 12 (27.3 %) | |
Grade3-5 Neutropenia | 0.513 | ||
No | 28 (63.6 %) | 25 (56.8 %) | |
Yes | 16 (36.4 %) | 19 (43.2 %) | |
Grade3-5 Thrombocytopenia | 0.817 | ||
No | 30 (68.2 %) | 31 (70.5 %) | |
Yes | 14 (31.8 %) | 13 (29.5 %) | |
Grade3-5 Mucositis | 0.001 | ||
No | 34 (77.3 %) | 44 (100.0 %) | |
Yes | 10 (22.7 %) | 0 (0 %) | |
Grade3-5 Xerostomia | 0.053 | ||
No | 35 (79.5 %) | 42 (95.5 %) | |
Yes | 9 (20.5 %) | 2 (4.5 %) | |
Grade3-5 Nasopharyngeal necrosis | <0.001 | ||
No | 27 (61.4 %) | 44 (100.0 %) | |
Yes | 17 (38.6 %) | 0 (0 %) | |
Grade3-5 Temporal lobe necrosis | 0.035 | ||
No | 36 (81.8 %) | 43 (97.7 %) | |
Yes | 8 (18.2 %) | 1 (2.3 %) | |
Grade3-5 Cranial neuropathy | 0.026 | ||
No | 38 (86.4 %) | 44 (100.0 %) | |
Yes | 6 (13.6 %) | 0 (0 %) | |
Grade3-5 Trismus | |||
No | 35 (79.5 %) | 44 (100.0 %) | 0.002 |
Yes | 9 (20.5 %) | 0 (0 %) | |
Grade3-5 Hearing loss | 0.001 | ||
No | 28 (63.6 %) | 42 (95.5 %) | |
Yes | 16 (36.4 %) | 2 (4.5 %) |